Latest Distributions News

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for 30 of its ETFs for the March 2026 distribution period, with elections due by 7 April and unit issuance scheduled for 20 April.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for its Australian High Interest Cash ETF and Cash Plus Active ETF for the March 2026 distribution period. Investors must submit DRP elections by 7 April 2026, with unit issuance scheduled for 13 April.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.

GCM Corporation has launched its first Very High Density (VHD) heat sink product line, marking a pivotal step from development to commercial sales in thermal management technology.

OMG Group has inked a collaboration with Sydney’s The Little Marionette to supply premium Japanese matcha, reinforcing its vertically integrated matcha strategy and expanding its reach into premium hospitality and retail sectors.

SportsHero Limited has secured a major content deal with Playades, adding over 400 popular mobile games to its HeroPlay platform and boosting subscriber growth in Southeast Asia ahead of the FIFA World Cup 2026.

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

Betashares Capital Ltd has announced the final distribution amounts for March 2026 across multiple ETFs on the ASX AQUA market, alongside details on the active Distribution Reinvestment Plan (DRP). Investors can expect payments in April with reinvestment prices to be revealed shortly.

Andromeda Metals faces uncertainty in securing cornerstone funding for its Great White Project due to Middle East geopolitical tensions, while pushing forward with its High Purity Alumina pilot plant commissioning.

Optiscan Imaging Ltd has taken a significant step towards commercialising its InSpecta® veterinary imaging device in the US by submitting a regulatory dossier to the FDA. This milestone not only initiates formal review but also sets the stage for broader clinical adoption and future device approvals.

Latrobe Magnesium has locked in a US$2 million non-dilutive prepayment from its US distribution partner to accelerate commissioning of its Demonstration Plant, aiming for first magnesium deliveries in late 2026.

Hastings Technology Metals has acquired a 49% stake in a fully permitted rare earth processing plant in Thailand, aiming to commence production by late 2026. This strategic move offers a lower-cost, near-term production hub with potential to process feedstock from its Yangibana project.